SARS-CoV-2, COVID-19

Evolutionary Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reveals Genomic Divergence with Implications for Universal Vaccine Efficacy

Vizitatori unici: 505

Nanda Kumar Yellapu, Shachi Patel, Bo Zhang, Richard Meier, Lisa Neums, Dong Pei, Qing Xia, Duncan Rotich, Rosalyn C. Zimmermann, Emily Nissen, Shelby Bell-Glenn, Whitney Shae, Jinxiang Hu, Prabhakar Chalise, Lynn Chollet-Hinton, Devin C. Koestler and Jeffery A. Thompson

SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden

Vizitatori unici: 460

Ann-Sofie Rudberg, Sebastian Havervall, Anna Månberg, August Jernbom Falk, Katherina Aguilera, Henry Ng, Lena Gabrielsson, Ann-Christin Salomonsson, Leo Hanke, Ben Murrell, Gerald McInerney, Jennie Olofsson, Eni Andersson, Cecilia Hellström, Shaghayegh Bayati, Sofia Bergström, Elisa Pin, Ronald Sjöberg, Hanna Tegel, My Hedhammar, Mia Phillipson, Peter Nilsson, Sophia Hober & Charlotte Thålin 

A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19

Vizitatori unici: 488

Xuping Xie, Antonio E. Muruato, Xianwen Zhang, Kumari G. Lokugamage, Camila R. Fontes-Garfias, Jing Zou, Jianying Liu, Ping Ren, Mini Balakrishnan, Tomas Cihlar, Chien-Te K. Tseng, Shinji Makino, Vineet D. Menachery, John P. Bilello & Pei-Yong Shi